基本信息
浏览量:66
职业迁徙
个人简介
Service: 2019-2025, NIH, MBPP study section permanent member; 2018 NIH, MBPP study section
ad hoc reviewer; 2011, VA-Scientific Review Group 2012/01 PULM 1; 2010, NIH, Director’s
Research Opportunity (RC-4) ZRG1 VH-D (55) R study section; 2009, NIH, Translational-NIH
Recovery Act Research Support Grant study section; 2009, ad hoc Reviewer NIH/National
Institute of Health, Erythrocyte and Leukocyte Biology (ELB) Study Section. 2009-present, ad hoc
Reviewer, Universidad de Buenos Aires, Argentina; 2009, ad hoc Reviewer, Medical Research
Council (MRC), U.K.; 2008-2009, ad hoc Reviewer, Netherlands Organization for Scientific
Research; 2008, 2004-2007, Study section, American Heart Association, Western States Affiliate.
Review and advisory Boards: 2016-Present, Scientific Review Board, Cystinosis Research
Foundation; 2014-present, Editorial Board, Journal of Biological Chemistry; 2012-2016/2018-
2020, International Scientific Advisory Board of the biennial symposium “Neutrophil in
Immunity”; Graduate Student advisory committee, Scripps Research.
Research Interests
My research focuses on questions of fundamental biological importance, including the study of
cellular mechanisms of innate immune cells with relevance in inflammation and host defense,
the analysis of molecular mechanisms that govern vesicular trafficking processes and regulate
cellular functions in inflammatory cells as well as the role of these mechanisms in in vivo models
of systemic inflammation. I also carry out research directed at elucidating molecular and cellular
determinants in autophagy and mechanisms in lysosomal storage disorders. I have developed
translational approaches and have identified novel small-molecule modulators of vesicular
trafficking and inhibitors of neutrophil exocytosis and have characterize modulators of
autophagic pathways, for potential therapeutic intervention in inflammation and other human
diseases.
Statement of Interest
I have worked in the field of neutrophil biology for over 25 years, since I was a graduate student
at University of Buenos Aires, in Argentina, and have continued those studies at The Scripps
Research Institute, both as a post-doctoral fellow and Professor. I have had the privilege to
interact and collaborate with many renown neutrophil biologist over the years, but it has been
my interaction with young graduate students and post-doctoral fellows that has inspired me the
most. I have witnessed first-hand the gradual development of their love for this research field.
It has been inspiring to have been a part of that and immensely satisfying to help these young
scientists find and follow their true passion, be it, in academia, drug discovery, biotech or policy
making. Based on my experience as a mentor, if elected as a SLB council, I will implement
mechanisms to help guide young scientist to find their interest and facilitate communication with
groups of interest to guide their paths into their future careers.
Originating from a scientific community where resources were not always readily available, I have
a great appreciation for the challenges often faced in such environments. If elected as a member
of the SLB council, I will work to develop mechanism to facilitate the availability and exchange of
resources between research laboratories in low income countries with groups with more readily
available resources. To this end, I will maximize communication between the USA SLB members
and members of the scientific communities in other countries. As an example, I am part of the
organization committee of the upcoming SLB satellite meeting concurrent with the Sociedad
Argentina de Inmunología, to take place in Mar del Plata, Argentina in 2020. Equally important, I
will also focus on increasing and maximizing the inclusion of minorities and under-represented
groups into the research field of leukocyte biology.
In conclusion, if elected to the council, I will work to develop mechanism to facilitate the
availability and exchange of resources between research laboratories in low income countries
with those with more resourceful groups as well as generate tools to help young scientists in their
early scientific careers. I believe that SLB provides an effective platform to facilitate the exchange
of ideas, work power and resources between groups, which I anticipate will benefit all
participants and the SLB scientific community as a whole.
ad hoc reviewer; 2011, VA-Scientific Review Group 2012/01 PULM 1; 2010, NIH, Director’s
Research Opportunity (RC-4) ZRG1 VH-D (55) R study section; 2009, NIH, Translational-NIH
Recovery Act Research Support Grant study section; 2009, ad hoc Reviewer NIH/National
Institute of Health, Erythrocyte and Leukocyte Biology (ELB) Study Section. 2009-present, ad hoc
Reviewer, Universidad de Buenos Aires, Argentina; 2009, ad hoc Reviewer, Medical Research
Council (MRC), U.K.; 2008-2009, ad hoc Reviewer, Netherlands Organization for Scientific
Research; 2008, 2004-2007, Study section, American Heart Association, Western States Affiliate.
Review and advisory Boards: 2016-Present, Scientific Review Board, Cystinosis Research
Foundation; 2014-present, Editorial Board, Journal of Biological Chemistry; 2012-2016/2018-
2020, International Scientific Advisory Board of the biennial symposium “Neutrophil in
Immunity”; Graduate Student advisory committee, Scripps Research.
Research Interests
My research focuses on questions of fundamental biological importance, including the study of
cellular mechanisms of innate immune cells with relevance in inflammation and host defense,
the analysis of molecular mechanisms that govern vesicular trafficking processes and regulate
cellular functions in inflammatory cells as well as the role of these mechanisms in in vivo models
of systemic inflammation. I also carry out research directed at elucidating molecular and cellular
determinants in autophagy and mechanisms in lysosomal storage disorders. I have developed
translational approaches and have identified novel small-molecule modulators of vesicular
trafficking and inhibitors of neutrophil exocytosis and have characterize modulators of
autophagic pathways, for potential therapeutic intervention in inflammation and other human
diseases.
Statement of Interest
I have worked in the field of neutrophil biology for over 25 years, since I was a graduate student
at University of Buenos Aires, in Argentina, and have continued those studies at The Scripps
Research Institute, both as a post-doctoral fellow and Professor. I have had the privilege to
interact and collaborate with many renown neutrophil biologist over the years, but it has been
my interaction with young graduate students and post-doctoral fellows that has inspired me the
most. I have witnessed first-hand the gradual development of their love for this research field.
It has been inspiring to have been a part of that and immensely satisfying to help these young
scientists find and follow their true passion, be it, in academia, drug discovery, biotech or policy
making. Based on my experience as a mentor, if elected as a SLB council, I will implement
mechanisms to help guide young scientist to find their interest and facilitate communication with
groups of interest to guide their paths into their future careers.
Originating from a scientific community where resources were not always readily available, I have
a great appreciation for the challenges often faced in such environments. If elected as a member
of the SLB council, I will work to develop mechanism to facilitate the availability and exchange of
resources between research laboratories in low income countries with groups with more readily
available resources. To this end, I will maximize communication between the USA SLB members
and members of the scientific communities in other countries. As an example, I am part of the
organization committee of the upcoming SLB satellite meeting concurrent with the Sociedad
Argentina de Inmunología, to take place in Mar del Plata, Argentina in 2020. Equally important, I
will also focus on increasing and maximizing the inclusion of minorities and under-represented
groups into the research field of leukocyte biology.
In conclusion, if elected to the council, I will work to develop mechanism to facilitate the
availability and exchange of resources between research laboratories in low income countries
with those with more resourceful groups as well as generate tools to help young scientists in their
early scientific careers. I believe that SLB provides an effective platform to facilitate the exchange
of ideas, work power and resources between groups, which I anticipate will benefit all
participants and the SLB scientific community as a whole.
研究兴趣
论文共 87 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Frontiers in Immunology (2023): 1224045-1224045
Yanfang Peipei Zhu,Mary Speir,Zhehao Tan,Jamie Casey Lee,Cameron J. Nowell,Alyce A. Chen,Hajera Amatullah,Ari J. Salinger, Carolyn J. Huang, Gio Wu,Weiqi Peng, Kasra Askari,
SCIENCE ADVANCESno. 51 (2023): eadj1397-eadj1397
Nature immunologyno. 12 (2023): 1970-1971
引用0浏览0WOSNATURE引用
0
0
JOURNAL OF IMMUNOLOGYno. 1 (2022)
Social Science Research Network (2021)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn